EchelonBiosciencesIncorporatedX品牌历史介绍:苏州蚂蚁淘生物科技有限公司,作为一家生命科学领域的高科技生物公司,目前代理销售二十多家欧美著名生物技术公司的产品,覆盖了免疫学、细胞生物学、分子生物学、药物筛选、生物制药、食品检测、疫苗生产等领域。
Echelon特色产品
Echelon产品线
LipidKinases&Phosphatases | |
Lipid-ProteinInteractionTools | 脂蛋白质相互作用工具 |
Lipid-SpecificAssayKits | |
Lipid-SpecificAntibodies&BindingProteins | |
HyaluronicAcid&CollaGEnIVAssayKits | |
SyntheticInositolphosphates,Lipids,&Phospholipids |
EchelonBiosciences目的在于进一步发展的脂质的细胞信号转导的关键代谢酶的科学,它提供了对癌症,心血管疾病疾病,糖尿病,炎症,感染的潜在的药物和诊断发展的新的和可行的目标。
EchelonBiosciences为生命科学社区提供的产品包括:
抗体 分析检测试剂盒
抑制剂 细胞信号产品
脂类代谢 标记物
Z-R015 Anti-huVps34(ClassIIIPI3-Kinase)AntibodyforIP
抗体 Z-R016 Anti-huVps34(ClassIIIPI3-Kinase)AntibodyforWB
K-1000 PI3-KELISAKit
试剂盒 K-1000S PI3-KELISA:PicoAssay
K-1100 PI3-KFluorescencePolarizationKit
K-1300 PI3-KAlphaScreen®
K-2700S TRueFRETPI3-KActivityAssay
K-3000 ClassIIIPI3-KELISAKit
P27-18H PI3-K(p-110alpha/p85alpha)ActiveEnzyme
酶 P28-10H PI3-K(p-110beta/p85alpha)ActiveEnzyme
B-0021 Resveratrol(ClassIAPI3-KInhibitor)
抑制剂 B-0222 Wortmannin(PI3-KinaseInhibitor)
B-0294 PI3-KinaseInhibitor(LY294002)
B-0301 PI3-KinaseGammaInhibitor1(AS605240)
B-0302 PI3-KinaseGammaInhibitor2(AS604850
B-0303 PI3-KinaseAlphaInhibitor1(PI-103)
B-0304 PI3-KinaseAlphaInhibitor2
EchelonBiosciences Incorporated(EBI)wasincorporatedunderthelawsofthestateofUtahasEchelonResearchLaboratories,Inc.onOctober3,1997.Initially, EchelonBiosciences EBIwasformedfromaprojectundertheCenterforCellSignaling,aStateofUtahCenterofExcellence,withtheaimtofurtherthescienceoflipidcellsignalingandcriticalmetabolicenzymes,whichprovidenewandviabletargetsforthedevelopmentofpotentialdrugsanddiagnosticsforcancer,diabetes,inflammation,infections,andcardiovasculardisease.
From1997through2004, EchelonBiosciences EBIprimarilyusedgovernmentgrantsandproductsalesrevenuestofunditsresearchefforts.Inearly2005,EBIwaspurchasedbyAeternaZentaris(NAS:AEZS)foritsMEPanti-infectives,PI3-Kinasesmallmoleculeprogram,catalogbusiness,andscientificexpertise.Inlate2007,FrontierScientificIncorporated(FSI)basedinLogan,UtahpurchasedEBI.Specializinginporphyrinandboronchemistry,FSIopenedthedoorsforexpandedresearch.
Since1997, EchelonBiosciences EBIhasretaineditscommitmenttodevelopingnovel*****sandreagentsforlipidresearchandbeyond.AtEBI’scoreisthedesiretoinnovate,thuspushingmedicinalresearchtonewlimits.Welookforwardtoprovidingscientistsaroundtheworldwiththetoolstheyneedtocurehumandiseasestatesforyearstocomeandwewelcomeanysuggestionsabouthowwecanbetterdoso.
